These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 21118965)

  • 1. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling.
    Sullivan JP; Spinola M; Dodge M; Raso MG; Behrens C; Gao B; Schuster K; Shao C; Larsen JE; Sullivan LA; Honorio S; Xie Y; Scaglioni PP; DiMaio JM; Gazdar AF; Shay JW; Wistuba II; Minna JD
    Cancer Res; 2010 Dec; 70(23):9937-48. PubMed ID: 21118965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
    Shao C; Sullivan JP; Girard L; Augustyn A; Yenerall P; Rodriguez-Canales J; Liu H; Behrens C; Shay JW; Wistuba II; Minna JD
    Clin Cancer Res; 2014 Aug; 20(15):4154-66. PubMed ID: 24907115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALDH maintains the stemness of lung adenoma stem cells by suppressing the Notch/CDK2/CCNE pathway.
    Li Z; Xiang Y; Xiang L; Xiao Y; Li F; Hao P
    PLoS One; 2014; 9(3):e92669. PubMed ID: 24671051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.
    Hassan KA; Wang L; Korkaya H; Chen G; Maillard I; Beer DG; Kalemkerian GP; Wicha MS
    Clin Cancer Res; 2013 Apr; 19(8):1972-80. PubMed ID: 23444212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo.
    Osanyingbemi-Obidi J; Dobromilskaya I; Illei PB; Hann CL; Rudin CM
    Mol Cancer Res; 2011 Dec; 9(12):1746-54. PubMed ID: 21994468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells.
    Zhao D; Mo Y; Li MT; Zou SW; Cheng ZL; Sun YP; Xiong Y; Guan KL; Lei QY
    J Clin Invest; 2014 Dec; 124(12):5453-65. PubMed ID: 25384215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
    Li X; Wan L; Geng J; Wu CL; Bai X
    J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
    Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
    J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
    Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
    Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
    Wei Y; Wu S; Xu W; Liang Y; Li Y; Zhao W; Wu J
    Thorac Cancer; 2017 Jan; 8(1):26-32. PubMed ID: 27813328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors.
    Patel M; Lu L; Zander DS; Sreerama L; Coco D; Moreb JS
    Lung Cancer; 2008 Mar; 59(3):340-9. PubMed ID: 17920722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
    Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
    Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-17-92/p38α Dysregulation Enhances Wnt Signaling and Selects Lgr6+ Cancer Stem-like Cells during Lung Adenocarcinoma Progression.
    Guinot A; Oeztuerk-Winder F; Ventura JJ
    Cancer Res; 2016 Jul; 76(13):4012-22. PubMed ID: 27197183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.
    Rasheed ZA; Yang J; Wang Q; Kowalski J; Freed I; Murter C; Hong SM; Koorstra JB; Rajeshkumar NV; He X; Goggins M; Iacobuzio-Donahue C; Berman DM; Laheru D; Jimeno A; Hidalgo M; Maitra A; Matsui W
    J Natl Cancer Inst; 2010 Mar; 102(5):340-51. PubMed ID: 20164446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
    Luo Y; Dallaglio K; Chen Y; Robinson WA; Robinson SE; McCarter MD; Wang J; Gonzalez R; Thompson DC; Norris DA; Roop DR; Vasiliou V; Fujita M
    Stem Cells; 2012 Oct; 30(10):2100-13. PubMed ID: 22887839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.